Publications by authors named "Jake Vinson"

11Publications

Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.

N Engl J Med 2016 Aug 6;375(5):443-53. Epub 2016 Jul 6.

From the University of Washington (C.C.P., M. Beightol, C.M., B.N., H.H.C., B.M., T.W., S. Casadei, P.S.N.) and Fred Hutchinson Cancer Research Center (N.D.S., R.G., P.S.N.) - both in Seattle; the Institute of Cancer Research and Royal Marsden Hospital, London (J.M., S. Carreira, R.E., J.B.); Memorial Sloan Kettering Cancer Center (M.F.W., W.A., M. Berger, L.Z., A.Z., J. Vijai, H.I.S., C.S., N.S., P.W.K., D.S., M.R., K.O.), Weill Cornell Medical College (H.B., O.E., M.A.R.), and the Prostate Cancer Clinical Trials Consortium (J. Vinson, J.F.) - all in New York; the University of Michigan, Ann Arbor (D.R., R.L., M.H., A.C.); Howard Hughes Medical Institute, Chevy Chase, MD (A.C., C.S.); and Dana-Farber Cancer Institute, Boston (A.G., L.G., M.-E.T., S.A., G.C.H., E.M.V.A.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1603144DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986616PMC
August 2016

Integrative clinical genomics of advanced prostate cancer.

Cell 2015 May;161(5):1215-1228

Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2015.05.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484602PMC
May 2015

Alterations in the serum glycome due to metastatic prostate cancer.

J Proteome Res 2007 May 14;6(5):1822-32. Epub 2007 Apr 14.

National Center for Glycomics and Glycoproteomics, Department of Chemistry, Indiana University, 800 East Kirkwood Avenue, Bloomington, Indiana 47405, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/pr060664tDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3685170PMC
May 2007

A phase II trial of irinotecan, 5-fluorouracil and leucovorin combined with celecoxib and glutamine as first-line therapy for advanced colorectal cancer.

Oncology 2005 2;69(1):63-70. Epub 2005 Aug 2.

Department of Medicine, Division of Hematology/Oncology, Indiana University School of Medicine, Indianapolis, Ind. 46202, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000087302DOI Listing
September 2005

A phase II trial of olanzapine for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier Oncology Group study.

Support Care Cancer 2005 Jul 8;13(7):529-34. Epub 2005 Feb 8.

Walter Cancer Research Center, University of Notre Dame, 250 Nieuwland Science Hall, Notre Dame, IN 46556, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-004-0755-6DOI Listing
July 2005

A phase I trial of olanzapine (Zyprexa) for the prevention of delayed emesis in cancer patients: a Hoosier Oncology Group study.

Cancer Invest 2004 ;22(3):383-8

Hoosier Oncology Group, Walther Cancer Institute, Indianapolis, Indiana, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1081/cnv-200029066DOI Listing
November 2004